These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16518628)

  • 1. Duration of extracorporeal therapy in acute maple syrup urine disease: a kinetic model.
    Phan V; Clermont MJ; Merouani A; Litalien C; Tucci M; Lambert M; Mitchell G; Jouvet P
    Pediatr Nephrol; 2006 May; 21(5):698-704. PubMed ID: 16518628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic modeling of plasma leucine levels during continuous venovenous extracorporeal removal therapy in neonates with maple syrup urine disease.
    Jouvet P; Hubert P; Saudubray JM; Rabier D; Man NK
    Pediatr Res; 2005 Aug; 58(2):278-82. PubMed ID: 16085796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined nutritional support and continuous extracorporeal removal therapy in the severe acute phase of maple syrup urine disease.
    Jouvet P; Jugie M; Rabier D; Desgrès J; Hubert P; Saudubray JM; Man NK
    Intensive Care Med; 2001 Nov; 27(11):1798-806. PubMed ID: 11810125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid clearance during acute metabolic decompensation in maple syrup urine disease treated with continuous venovenous hemodialysis with filtration.
    Hmiel SP; Martin RA; Landt M; Levy FH; Grange DK
    Pediatr Crit Care Med; 2004 May; 5(3):278-81. PubMed ID: 15115568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous Venovenous Hemodiafiltration in the Treatment of Maple Syrup Urine Disease.
    Demirkol D; Şık G; Topal N; Çıtak A; Zeybek Ç; Tüten A; Bilge I
    Blood Purif; 2016; 42(1):27-32. PubMed ID: 26998605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous venovenous haemodiafiltration in the acute phase of neonatal maple syrup urine disease.
    Jouvet P; Poggi F; Rabier D; Michel JL; Hubert P; Sposito M; Saudubray JM; Man NK
    J Inherit Metab Dis; 1997 Aug; 20(4):463-72. PubMed ID: 9266382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance of branched chain amino acids by peritoneal dialysis in maple syrup urine disease.
    McMahon Y; MacDonnell RC
    Adv Perit Dial; 1990; 6():31-4. PubMed ID: 1982835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of maple syrup urine disease with high flow hemodialysis in a neonate.
    Aygün F; Kıykım E; Aktuğlu-Zeybek Ç; Zubarioğlu T; Cam H
    Turk J Pediatr; 2019; 61(1):107-110. PubMed ID: 31559730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein and leucine metabolism in maple syrup urine disease.
    Thompson GN; Bresson JL; Pacy PJ; Bonnefont JP; Walter JH; Leonard JV; Saudubray JM; Halliday D
    Am J Physiol; 1990 Apr; 258(4 Pt 1):E654-60. PubMed ID: 2185648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term metabolic follow-up and clinical outcome of 35 patients with maple syrup urine disease.
    Abi-Wardé MT; Roda C; Arnoux JB; Servais A; Habarou F; Brassier A; Pontoizeau C; Barbier V; Bayart M; Leboeuf V; Chadefaux-Vekemans B; Dubois S; Assoun M; Belloche C; Alili JM; Husson MC; Lesage F; Dupic L; Theuil B; Ottolenghi C; de Lonlay P
    J Inherit Metab Dis; 2017 Nov; 40(6):783-792. PubMed ID: 28905140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of acute metabolic decompensation in children with maple syrup urine disease at the emergency department.
    Yıldız Y; Akcan Yıldız L; Dursun A; Tokatlı A; Coşkun T; Tekşam Ö; Sivri HS
    Eur J Pediatr; 2020 Jul; 179(7):1107-1114. PubMed ID: 32048023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Removal of branched-chain amino acids by peritoneal dialysis, continuous arteriovenous hemofiltration, and continuous arteriovenous hemodialysis in rabbits: implications for maple syrup urine disease treatment.
    Gouyon JB; Desgres J; Mousson C
    Pediatr Res; 1994 Mar; 35(3):357-61. PubMed ID: 8190527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of the acute crisis in maple syrup urine disease.
    Nyhan WL; Rice-Kelts M; Klein J; Barshop BA
    Arch Pediatr Adolesc Med; 1998 Jun; 152(6):593-8. PubMed ID: 9641714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of whole body L-leucine oxidation by noninvasive L-[1-13C]leucine breath tests: a reappraisal in patients with maple syrup urine disease, obligate heterozygotes, and healthy subjects.
    Schadewaldt P; Bodner A; Brösicke H; Hammen HW; Wendel U
    Pediatr Res; 1998 May; 43(5):592-600. PubMed ID: 9585004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-body L-leucine oxidation in patients with variant form of maple syrup urine disease.
    Schadewaldt P; Bodner-Leidecker A; Hammen HW; Wendel U
    Pediatr Res; 2001 May; 49(5):627-35. PubMed ID: 11328944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute illness in maple syrup urine disease: dynamics of protein metabolism and implications for management.
    Thompson GN; Francis DE; Halliday D
    J Pediatr; 1991 Jul; 119(1 Pt 1):35-41. PubMed ID: 2066856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Maple syrup urine disease with an intermittent relatively benign course].
    Müller H; Bickel H; Feist D; Lutz P
    Dtsch Med Wochenschr; 1971 Oct; 96(40):1552-7. PubMed ID: 5093339
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of acute metabolic decompensation in maple syrup urine disease: a multi-center study.
    Yoshino M; Aoki K; Akeda H; Hashimoto K; Ikeda T; Inoue F; Ito M; Kawamura M; Kohno Y; Koga Y; Kuroda Y; Maesaka H; Murakamisoda H; Sugiyama N; Suzuki Y; Yano S; Yoshioka A
    Pediatr Int; 1999 Apr; 41(2):132-7. PubMed ID: 10221014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of acute decompensation of neonatal maple syrup urine disease with continuous arteriovenous haemofiltration: report of one case.
    Lin MC; Chen CH; Fu LS; Jan SL; Shu SG; Chi CS
    Acta Paediatr Taiwan; 2002; 43(5):281-4. PubMed ID: 12607485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction of hyperleucinemia in MSUD patients on leucine-free dietary therapy.
    Scott AI; Cusmano-Ozog K; Enns GM; Cowan TM
    Mol Genet Metab; 2017 Dec; 122(4):156-159. PubMed ID: 29032949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.